Cabotegravir | B2535

Cabotegravir is a long acting HIV-1 integrase inhibitor that displays activity against a broad range of HIV subtypes.

Cabotegravir is a long acting HIV-1 integrase inhibitor that displays activity against a broad range of HIV subtypes.

B2535 | Cabotegravir DataSheet

Alternate Name/Synonyms: GSK-744; S/GSK1265744; N-((2,4-Difluorophenyl)methyl)-6-hydroxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro(1,3)oxazolo(3,2-a)pyrido(1,2-d)pyrazine-8-carboxamide

Appearance: White to off-white solid

Formulation:

CAS Number: 1051375-10-0

Structure Available?: Yes

Peptide sequence: N/A

Salt Form: No

Molecular Formula: C₁₉H₁₇F₂N₃O₅

Molecular Weight: 405.35

Cell-Permeable?: True

Purity: ≥98%

Solubilities: >10 mg/ml in DMSO

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A long acting HIV-1 integrase inhibitor

MDL Number:

PubChem CID: 54713659

SMILES: CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O

InChi: InChI=1S/C19H17F2N3O5/c1-9-8-29-14-7-23-6-12(16(25)17(26)15(23)19(28)24(9)14)18(27)22-5-10-2-3-11(20)4-13(10)21/h2-4,6,9,14,26H,5,7-8H2,1H3,(H,22,27)/t9-,14+/m0/s1

InChi Key: WCWSTNLSLKSJPK-LKFCYVNXSA-N